PHARMALA BIOTECH HOLDINGS INC.

Insiders Pharmala Biotech Holdings Inc.

Equities

MDMA

CA71719L1067

Market Closed - Canadian Securities Exchange Other stock markets 03:59:51 2024-05-09 pm EDT			5-day change	1st Jan Change
0.19 ^CAD	-7.32%		0.00%	+35.71%

May. 03	PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy	MT
Apr. 23	Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PharmAla Named an Intellectual Property Ontario Client	Feb. 22	MT
Pharmala Biotech Names Exclusive MDMA Supply Partner to Awakn Life Sciences	23-03-02	CI
PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences	23-03-02	GL
PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences	23-03-02	AQ
PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics	23-02-06	GL
PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics	23-02-06	AQ
Pharmala Biotech Appoints Dr. Leah Mayo to Scientific Advisory Board	22-10-13	CI
PharmAla Biotech named Exclusive MDMA Supplier to InterVivo Solutions	22-08-05	AQ
Pharmala Biotech Names Exclusive Mdma Supplier to Intervivo Solutions	22-08-05	CI
Pharmala Biotech Holdings Inc. Appoints Kevin Roy to Its Board of Directors	22-07-04	CI
Pharmala Biotech Holdings Inc. Appoints David Purcell as Director of Sales	22-03-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW